
ALT Promotional graphic for CME Institute Forum on 'Assessing Progress in FSHD Treatment Options' scheduled for Wednesday, October 16, 2024, featuring an illustration of a healthcare professional presenting to a group of attentive colleagues. The session is supported by Fulcrum Therapeutics and is part of the official scientific program of the AANEM. Time of the event is from 11:45am to 12:45pm EDT.

ALT The image shows a promotional graphic from CME Institute, outlining a weekly continuing medical education (CME) roundup, featuring courses on non-dopaminergic mechanisms in Parkinson's, understanding advanced COPD symptoms, facioscapulohumeral muscular dystrophy (FSHD) diagnosis, and Duchenne muscular dystrophy treatment with Vamorolone, including credit details for AMA PRA Category 1.















